Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

ATM/Wip1 activities at chromatin control Plk1 re-activation to determine G2 checkpoint duration

H. Jaiswal, J. Benada, E. Müllers, K. Akopyan, K. Burdova, T. Koolmeister, T. Helleday, RH. Medema, L. Macurek, A. Lindqvist,

. 2017 ; 36 (14) : 2161-2176. [pub] 20170612

Language English Country England, Great Britain

Document type Journal Article

After DNA damage, the cell cycle is arrested to avoid propagation of mutations. Arrest in G2 phase is initiated by ATM-/ATR-dependent signaling that inhibits mitosis-promoting kinases such as Plk1. At the same time, Plk1 can counteract ATR-dependent signaling and is required for eventual resumption of the cell cycle. However, what determines when Plk1 activity can resume remains unclear. Here, we use FRET-based reporters to show that a global spread of ATM activity on chromatin and phosphorylation of ATM targets including KAP1 control Plk1 re-activation. These phosphorylations are rapidly counteracted by the chromatin-bound phosphatase Wip1, allowing cell cycle restart despite persistent ATM activity present at DNA lesions. Combining experimental data and mathematical modeling, we propose a model for how the minimal duration of cell cycle arrest is controlled. Our model shows how cell cycle restart can occur before completion of DNA repair and suggests a mechanism for checkpoint adaptation in human cells.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17030755
003      
CZ-PrNML
005      
20171025115352.0
007      
ta
008      
171025s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.15252/embj.201696082 $2 doi
035    __
$a (PubMed)28607002
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Jaiswal, Himjyot $u Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
245    10
$a ATM/Wip1 activities at chromatin control Plk1 re-activation to determine G2 checkpoint duration / $c H. Jaiswal, J. Benada, E. Müllers, K. Akopyan, K. Burdova, T. Koolmeister, T. Helleday, RH. Medema, L. Macurek, A. Lindqvist,
520    9_
$a After DNA damage, the cell cycle is arrested to avoid propagation of mutations. Arrest in G2 phase is initiated by ATM-/ATR-dependent signaling that inhibits mitosis-promoting kinases such as Plk1. At the same time, Plk1 can counteract ATR-dependent signaling and is required for eventual resumption of the cell cycle. However, what determines when Plk1 activity can resume remains unclear. Here, we use FRET-based reporters to show that a global spread of ATM activity on chromatin and phosphorylation of ATM targets including KAP1 control Plk1 re-activation. These phosphorylations are rapidly counteracted by the chromatin-bound phosphatase Wip1, allowing cell cycle restart despite persistent ATM activity present at DNA lesions. Combining experimental data and mathematical modeling, we propose a model for how the minimal duration of cell cycle arrest is controlled. Our model shows how cell cycle restart can occur before completion of DNA repair and suggests a mechanism for checkpoint adaptation in human cells.
650    _2
$a ATM protein $x metabolismus $7 D064007
650    _2
$a proteiny buněčného cyklu $x metabolismus $7 D018797
650    _2
$a buněčné linie $7 D002460
650    _2
$a chromatin $x metabolismus $7 D002843
650    _2
$a rezonanční přenos fluorescenční energie $7 D031541
650    12
$a kontrolní body fáze G2 buněčného cyklu $7 D059565
650    _2
$a lidé $7 D006801
650    _2
$a biologické modely $7 D008954
650    _2
$a teoretické modely $7 D008962
650    _2
$a fosforylace $7 D010766
650    _2
$a mapování interakce mezi proteiny $7 D025941
650    _2
$a proteinfosfatasa 2C $x metabolismus $7 D000071636
650    _2
$a posttranslační úpravy proteinů $7 D011499
650    _2
$a protein-serin-threoninkinasy $x metabolismus $7 D017346
650    _2
$a protoonkogenní proteiny $x metabolismus $7 D011518
650    _2
$a represorové proteiny $x metabolismus $7 D012097
655    _2
$a časopisecké články $7 D016428
700    1_
$a Benada, Jan $u Laboratory of Cancer Cell Biology, Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic. Faculty of Science, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Müllers, Erik $u Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Akopyan, Karen $u Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden. $7 gn_A_00003024
700    1_
$a Burdova, Kamila $u Laboratory of Cancer Cell Biology, Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Koolmeister, Tobias $u Department of Medical Biochemistry and Biophysics, and Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Helleday, Thomas $u Department of Medical Biochemistry and Biophysics, and Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Medema, René H $u Division of Cell Biology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
700    1_
$a Macurek, Libor $u Laboratory of Cancer Cell Biology, Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic libor.macurek@img.cas.cz arne.lindqvist@ki.se.
700    1_
$a Lindqvist, Arne $u Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden libor.macurek@img.cas.cz arne.lindqvist@ki.se.
773    0_
$w MED00181668 $t The EMBO journal $x 1460-2075 $g Roč. 36, č. 14 (2017), s. 2161-2176
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28607002 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171025115434 $b ABA008
999    __
$a ok $b bmc $g 1254348 $s 991782
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 36 $c 14 $d 2161-2176 $e 20170612 $i 1460-2075 $m The EPMA journal $n EPMA J $x MED00181668
LZP    __
$a Pubmed-20171025

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...